Tweetovi

Blokirali ste korisnika/cu @Asphalion

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Asphalion

  1. Prikvačeni tweet
    31. sij

    We’re pleased to announce the opening of a located in the to help you to overcome regulatory challenges. Check our services in the new website page and/or contact our new office in today at london@asphalion.com

    Poništi
  2. prije 13 sati

    is very pleased to announce the start of the collaboration with for the provision of / services in the UK. Read more:

    Poništi
  3. prije 19 sati

    The has awarded a grant of 6,4€ million for the research project to improve treatment options for patients with large bone defects. Today, is attending the SBR project kick-off meeting.

    Poništi
  4. 31. sij

    Are you attending the conference in Amsterdam? Our experts are waiting to meet you at 2. Stop by and find out more details about our and in the . They are looking forward to meet you!

    Poništi
  5. proslijedio/la je Tweet
    31. sij

    La consultora Asphalion no le teme al Brexit: abre oficinas en Londres

    Poništi
  6. 31. sij

    Complex are being discussed in the Development Session at the conference in Amsterdam!

    Poništi
  7. 30. sij

    Ms Beata Stepniewska, Deputy Director General and Head of Regulatory Affairs at , presented key points to increase patients' access to medicines.

    Poništi
  8. 30. sij
    Poništi
  9. proslijedio/la je Tweet
    29. sij

    Today we have published the key principles for the use of electronic product information () for EU medicines. Read what benefits ePI can deliver for : ➡️

    Poništi
  10. proslijedio/la je Tweet
    , , i još njih 2
    Poništi
  11. proslijedio/la je Tweet
    27. sij

    This week marks EMA’s 25th anniversary. Learn more about the key milestones and achievements in the authorisation and safety monitoring of for human and animal use in the EU since EMA’s establishment in 1995: 👉

    Poništi
  12. proslijedio/la je Tweet
    27. sij
    Poništi
  13. 27. sij

    : El 10/03 participará en la Jornada de SL “: Regulación y expectativas de cumplimiento". Para , consultas y completo de la jornada, sigue el siguiente enlace:

    Poništi
  14. 24. sij

    It seems that this new decade will become the decade of data. is intended to be implemented during the next years, but before this, there's a lot work to do to improve data quality knowledge and create new processes based on . Read more:

    Poništi
  15. proslijedio/la je Tweet
    23. sij

    What are the Notified Bodies designated so far under the MDR? We have compiled a complete list:

    Poništi
  16. proslijedio/la je Tweet

    🆕 We welcome today's ruling confirming public access to clinical study trials. ⚖️ judgement 👉 We worked with over many years for greater transparency in this area 👇

    Poništi
  17. proslijedio/la je Tweet
    22. sij

    Yesterday European Commission has published a state-of-play of joint assessments of Notified Bodies in the sector. The total number of applications is 55: 44 applications were done for the and 11 for the :

    Poništi
  18. proslijedio/la je Tweet

    Falsified medicines are often disguised as authentic medicines but may contain ingredients of bad or toxic quality, or in the wrong dosage Learn more about how the EU is contributing to the fight against medicine falsifications

    Poništi
  19. proslijedio/la je Tweet

    On - 4 February 2020 - will launch inclusive, EU-wide discussions on the : one of the main priorities in the area of health. Full details of the launch event in the here:

    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    16. sij

    While is one of the greatest threats to , 5.7 million people still die from treatable bacterial infections due to a lack of access to . See how members are engaging in programmes to address this:

    , , i još njih 7
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·